Tumor Ablation Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Tumor Ablation Market Size 2024-2028

The tumor ablation market size is forecast to increase by USD 1.43 billion, at a CAGR of 14.62% between 2023 and 2028.

• The market is witnessing significant growth, driven by the increasing preference for minimally invasive procedures in cancer treatment. This trend is fueled by the advantages of tumor ablation over traditional surgical methods, such as reduced recovery time, lower risk of complications, and minimal scarring. Another key driver is the increasing adoption of image-guided tumor ablation techniques, which offer improved accuracy and precision in targeting tumors, enhancing treatment efficacy. However, the market also faces challenges, primarily due to the technological complexities associated with tumor ablation. These complexities include the need for specialized equipment and skilled personnel, which can increase the cost of treatment and limit its accessibility.
• Additionally, the lack of standardization in tumor ablation procedures and the need for ongoing research to improve treatment outcomes pose further challenges. Companies seeking to capitalize on market opportunities must invest in research and development to address these challenges and offer innovative, cost-effective solutions. By focusing on improving the accessibility and affordability of tumor ablation treatments, while maintaining high levels of accuracy and precision, these companies can effectively navigate the market landscape and meet the evolving needs of patients and healthcare providers.

What will be the Size of the Tumor Ablation Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in technology and growing demand for minimally invasive treatment options. The use of ablation techniques, such as radiofrequency, microwave, and laser, is expanding across various sectors, including oncology and interventional radiology. Cooling systems and tissue response analysis play crucial roles in ensuring effective ablation and minimizing complications. Ablation catheters, guided by image technology, enable precise electrode placement, while laparoscopic ablation offers advantages in terms of reduced invasiveness and quicker recovery times. Tumor ablation monitoring and temperature monitoring systems facilitate real-time assessment of treatment progress, ensuring optimal ablation efficacy. Percutaneous ablation, with its minimal incision requirements, is gaining popularity due to its convenience and cost-effectiveness.

Ablation needle design and energy source parameters are continually being refined to enhance ablation zone assessment and improve safety protocols. Complication management and recurrence rate reduction are key areas of focus, with ongoing research aimed at minimizing risks and optimizing treatment outcomes. Local tumor control is a primary goal, with thermal dose calculation and necrosis induction being essential aspects of ablation procedures. The design of ablation devices continues to evolve, with a focus on enhancing patient selection criteria and improving treatment protocols. High-intensity focused ultrasound is another emerging technology in the tumor ablation landscape, offering potential benefits in terms of precision and efficacy.

The market's continuous dynamism is underpinned by ongoing research and development efforts, ensuring the delivery of innovative solutions for effective tumor ablation.

How is this Tumor Ablation Industry segmented?

The tumor ablation industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • Radiofrequency ablation
  • Microwave ablation
  • Cryoablation
  • Others
• Application
  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Breast and others
• Geography
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
  • APAC
    • China
  • Rest of World (ROW)

By Type Insights

The radiofrequency ablation segment is estimated to witness significant growth during the forecast period.

Radiofrequency ablation is a minimally invasive tumor treatment that utilizes image-guided electrode placement to deliver thermal energy and induce necrosis in targeted tumor areas. This procedure, which employs radiofrequency pulses, is favored by patients due to its shorter hospital stays, quicker recovery times, and lower risk of complications compared to traditional open surgeries. Radiofrequency ablation has demonstrated efficacy in treating various tumor types, including liver, lung, kidney, and bone metastases. Clinical studies indicate that this procedure can achieve successful tumor ablation, leading to significant lesion volume reduction and improved patient outcomes. Treatment planning software and electrode placement are crucial components of radiofrequency ablation, ensuring precise energy delivery and minimizing the risk of complications.

Safety protocols, including cooling systems and tissue response analysis, are implemented to mitigate potential risks. Ablation catheters and needles are designed to optimize energy delivery and thermal dose calculation for local tumor control. High-intensity focused ultrasound and microwave ablation are alternative thermal ablation techniques. Thermal ablation procedures, including radiofrequency ablation, rely on energy source parameters and ablation temperature monitoring to ensure proper tissue coagulation. Ablation zone assessment and complication management are essential aspects of these treatments. Patient selection criteria and energy delivery systems are critical factors in procedure success rate and recurrence rate. Innovations in ablation device design, such as image-guided and laparoscopic ablation, have expanded the application of these minimally invasive procedures.

Radiofrequency ablation's minimally invasive nature, high ablation efficacy, and favorable patient outcomes continue to drive its popularity and growth in the market.

Request Free Sample

The Radiofrequency ablation segment was valued at USD 455.26 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Request Free Sample

The market in North America is experiencing significant growth due to the rising prevalence of cancer, particularly in conditions such as liver, lung, and renal cancer. With an aging population and persistent risk factors like obesity and smoking, the incidence of cancer continues to increase, expanding the patient base for ablation treatments. In 2022, approximately 1.92 million new cancer cases and 609,360 cancer deaths were reported in the US, equating to around 1,670 deaths daily. Lung cancer, with approximately 350 deaths per day, is the leading cause of cancer-related fatalities. The increasing healthcare expenditure in North America, coupled with favorable reimbursement policies for cancer treatments, is further fueling the adoption of minimally invasive ablation procedures, including laser ablation, radiofrequency ablation, microwave ablation, and high-intensity focused ultrasound.

These techniques offer advantages such as shorter treatment duration, reduced lesion volume, improved procedure success rate, and enhanced patient safety through the use of treatment planning software, tissue coagulation, safety protocols, cooling systems, tissue response analysis, ablation catheters, image-guided ablation, electrode placement, laparoscopic ablation, tumor ablation monitoring, ablation temperature monitoring, percutaneous ablation, ablation needle design, energy source parameters, ablation zone assessment, complication management, recurrence rate, and necrosis induction. Ablation devices are designed with advanced features, such as thermal dose calculation and energy delivery systems, to ensure optimal ablation efficacy and local tumor control.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Tumor Ablation Industry?

• The increasing demand for minimally invasive procedures serves as the primary market driver.

• Minimally invasive tumor ablation techniques, including radiofrequency ablation, microwave ablation, cryoablation, and high intensity focused ultrasound (HIFU) ablation, offer cancer patients less invasive alternatives to traditional open surgery. These procedures utilize tissue coagulation, heat, or cold to destroy tumors, resulting in reduced morbidity and mortality rates compared to surgical resection. Treatment planning software aids in the precise targeting of lesions, ensuring optimal treatment duration and ablation efficacy. The safety protocols implemented during these procedures minimize the risk of complications, making minimally invasive tumor ablation an attractive option for patients with comorbidities or advanced-stage disease. Procedure success rates are high, with many patients experiencing quicker recovery times and shorter hospital stays.
• The benefits of minimally invasive tumor ablation extend beyond improved patient outcomes. These procedures offer less postoperative pain, quicker return to normal activities, and an overall enhancement of patient satisfaction. As technology advances, the use of laser ablation and other innovative ablation techniques continues to evolve, further increasing the potential for successful treatment and improved patient care.

What are the market trends shaping the Tumor Ablation Industry?

• The increasing adoption of image-guided tumor ablation is a significant market trend in the healthcare industry. This advanced medical technique allows for precise and effective tumor destruction, making it a preferred option for patients seeking alternative treatments to surgery.

• Image-guided tumor ablation procedures, utilizing technologies such as ultrasound, CT, Magnetic Resonance Imaging (MRI), and fluoroscopy, offer real-time visualization of tumors and surrounding structures. This enhances treatment precision by enabling accurate energy delivery to the tumor, minimizing damage to healthy tissue, and improving treatment efficacy. Real-time imaging guidance during ablation procedures ensures safe and effective execution, allowing physicians to monitor the extent of the tumor and make necessary adjustments to optimize outcomes while minimizing risks. The integration of image-guided ablation with navigation systems and software platforms further enhances treatment precision and workflow efficiency. Cooling systems play a crucial role in tumor ablation procedures, mitigating the risk of thermal damage to surrounding healthy tissue.
• Tissue response analysis is another essential aspect of tumor ablation, ensuring the ablation temperature remains within the therapeutic range for optimal treatment efficacy. Ablation catheters, used in both laparoscopic and percutaneous ablation procedures, facilitate the delivery of energy to the tumor site. Ablation temperature monitoring is essential for ensuring the efficacy and safety of the procedure, providing real-time feedback to the physician. In conclusion, image-guided tumor ablation, cooling systems, tissue response analysis, ablation catheters, and ablation temperature monitoring are key components of successful tumor ablation procedures. These technologies enhance treatment precision, minimize risks, and optimize treatment outcomes.

What challenges does the Tumor Ablation Industry face during its growth?

• The technological complexities surrounding tumor ablation represent a significant challenge to the industry's growth, as this minimally invasive cancer treatment requires precise and effective application of thermal or chemical energy to destroy tumors while minimizing damage to healthy surrounding tissue.

• Tumor ablation, a minimally invasive procedure for treating various types of tumors, involves the precise delivery of energy to destroy cancerous cells. Advanced ablation techniques, including microwave ablation, irreversible electroporation (IRE), and high-intensity focused ultrasound (HIFU), require specialized equipment and devices for effective tumor targeting. The complexity of these devices poses challenges for healthcare providers in terms of setup, operation, and maintenance. Successful tumor ablation depends on the accurate selection of patient criteria, appropriate energy source parameters, and effective ablation zone assessment. Healthcare providers must possess a deep understanding of different ablation modalities and their principles to ensure safe and effective treatment.
• Real-time imaging guidance, such as ultrasound, CT, or MRI, plays a crucial role in visualizing the tumor and monitoring treatment progress. Complication management is another critical aspect of tumor ablation procedures. Healthcare providers must be prepared to address potential complications, such as bleeding, infection, and damage to surrounding healthy tissues. Recurrence rate is also a significant concern, emphasizing the importance of proper patient selection, appropriate treatment parameters, and effective ablation zone assessment. In conclusion, tumor ablation is a complex and specialized procedure that demands the expertise and proficiency of healthcare providers. By understanding the principles of various ablation modalities, selecting appropriate treatment parameters, and utilizing real-time imaging guidance, providers can ensure the safe and effective delivery of tumor ablation treatments.

Exclusive Customer Landscape

The tumor ablation market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the tumor ablation market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, tumor ablation market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Alpinion Medical Systems Co. Ltd. - The StarBurst Radiofrequency Ablation System, a leading tumor ablation technology, sets itself apart with real-time tissue monitoring at the ablation margin.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Alpinion Medical Systems Co. Ltd.
• AngioDynamics Inc.
• Apyx Medical Corp.
• Bioventus LLC
• Boston Scientific Corp.
• BVM Medical Ltd.
• EDAP TMS
• ForTec Medical
• IceCure Medical Ltd.
• Johnson and Johnson Services Inc.
• Medtronic Plc
• Merit Medical Systems Inc.
• Mermaid Medical Group
• Monteris Medical Corp.
• Olympus Europa SE and Co. KG
• Profound Medical Corp.
• Smith and Nephew plc
• Stryker Corp.
• TechsoMed Medical Technologies Ltd.
• Terumo Corp.
• Varian Medical Systems Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Tumor Ablation Market

• In January 2024, Medtronic plc, a global healthcare solutions company, announced the U.S. Food and Drug Administration (FDA) approval of its new Microwave Ablation System, expanding its tumor ablation portfolio (Medtronic Press Release, 2024). This approval marked a significant technological advancement in the market, offering an alternative to traditional surgical methods.
• In March 2024, Merit Medical Systems, Inc. and AngioDynamics, Inc. entered into a definitive agreement to merge, creating a leading interventional medical devices company. The merger aimed to strengthen their positions in the market by combining their complementary product portfolios and expanding their global reach (Merit Medical Systems, Inc. Press Release, 2024).
• In April 2025, Boston Scientific Corporation received FDA approval for its ExAblate 2100 system, a high-intensity focused ultrasound (HIFU) ablation system for the ablation of soft tissue, including liver and kidney tumors. This approval represented a significant strategic partnership between Boston Scientific and Insightec Ltd., the developer of the ExAblate technology (Boston Scientific Corporation Press Release, 2025).
• In May 2025, AngioDynamics, Inc. completed the acquisition of BioSphere Medical, a privately held medical device company specializing in the development and commercialization of innovative ablation technologies. The acquisition aimed to strengthen AngioDynamics' position in the market by adding BioSphere's proprietary Sphereablation technology to its portfolio (AngioDynamics, Inc. Press Release, 2025).

Research Analyst Overview

• The market encompasses various minimally invasive procedures used to destroy targeted cancerous tissues, including lung and prostate ablation. Ablation systems employ different techniques such as thermal injury, real-time imaging, and temperature mapping to ensure precise lesion tracking and treatment planning. Oncological ablation and neurological ablation are gaining traction due to their effectiveness in treating various types of malignancies and neurological conditions. Targeted ablation procedures, like kidney and liver ablation, rely on advanced imaging techniques and monitoring systems to optimize energy deposition and treatment efficacy. Ablation complications, such as tissue damage and thermal injury, are minimized through advanced ablation technology and heat transfer modeling.
• Interventional radiology plays a crucial role in the ablation procedure, ensuring accurate and safe ablation outcomes. The market is driven by the increasing demand for less invasive cancer treatments and advancements in ablation technology. Patient outcomes are a key focus, with ongoing research exploring the impact of tissue characteristics on ablation effectiveness. Bone ablation is another emerging application, offering an alternative to surgical ablation for certain conditions. The market is expected to grow as the benefits of ablation procedures become more widely recognized and accepted by the medical community. In the realm of ablation technology, advancements in targeted ablation systems and imaging techniques are driving innovation and improving patient outcomes.
• The integration of advanced monitoring systems and treatment optimization strategies is further enhancing the efficacy of ablation procedures. Ablation power output and energy deposition are critical factors in the success of ablation procedures, with ongoing research aimed at optimizing these parameters for various applications. The future of the market lies in the continued development of advanced ablation systems and the integration of these technologies into clinical practice.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Tumor Ablation Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Tumor Ablation Market Research and Growth Report?

• CAGR of the Tumor Ablation industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the tumor ablation market growth of industry companies

We can help! Our analysts can customize this tumor ablation market research report to meet your requirements.

Get in touch